Insiders · Profile

Davis Blaine

Chief Financial Officer at Cartesian Therapeutics · Chief Financial Officer at Protara Therapeutics. Filing since 22 Sep 2020. CIK 0001802188

Company
Date
Role
Action
Shares
Amount
Of holding
6 Jan 2026
Chief Financial Officer
Sold at will
10,591
$72.23K
8.0%
6 Jan 2025
Chief Financial Officer
Sold at will
4,028
$67.80K
4.1%
3 Jan 2025
Chief Financial Officer
Sold at will
3,961
$66.24K
3.9%
22 Sep 2020
Chief Financial Officer
Bought
1,481
$25.04K
opened
4 decisions on file.